Standout Papers

Nivolumab in patients with metastatic DNA mismatch ... 2009 2026 2014 2020 1.9k
  1. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study (2017)
    Michael J. Overman, Ray McDermott et al. The Lancet Oncology
  2. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer (2018)
    Michael J. Overman, Sara Lonardi et al. Journal of Clinical Oncology
  3. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy (2009)
    Scott Kopetz, George J. Chang et al. Journal of Clinical Oncology
  4. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 (2019)
    Jonathan M. Loree, Seerat Anand et al. JAMA Oncology
  5. Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 (2022)
    Thierry André, Sara Lonardi et al. Annals of Oncology

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 75 standout
Sub-graph 1 of 22

Citing Papers

Colorectal cancer
2024 Standout
Adagrasib in Advanced Solid Tumors Harboring aKRASG12CMutation
2023 Standout
27 intermediate papers

Works of Michael J. Overman being referenced

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
2022 Standout
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery
2017
and 24 more

Author Peers

Author Last Decade Papers Cites
Michael J. Overman 10938 3940 2991 3816 443 15.9k
Takayuki Yoshino 11568 4126 3052 5388 697 15.3k
Stefano Cascinu 10996 2511 3338 7058 643 17.8k
Ian Chau 12763 2528 2318 6982 463 18.2k
Jinru Shia 12327 4498 3061 3852 367 18.5k
Timothy Price 10428 3014 2247 4891 464 14.4k
Ho Yeong Lim 6235 2364 2553 5478 365 14.2k
Joon Oh Park 9002 2032 2818 7439 378 15.8k
Axel Grothey 13763 3824 2440 4716 329 18.0k
Niall C. Tebbutt 9052 2549 1911 4293 250 12.5k
Valérie Boige 9238 2380 1918 6005 282 17.2k

All Works

Loading papers...

Rankless by CCL
2026